The bacterial toxins, choleragen and pertussis toxin, inhibit the light-stimulated GTPase activity of bovine retinal rod outer segments by catalysing the ADP-ribosylation of the a-subunit (Ta) of transducin [Abood, Hurley, Pappone, Bourne & Stryer (1982) 
INTRODUCTION
Transducin (T), a guanine nucleotide-binding protein of retinal rod cells, regulates signal coupling during the early stages of visual excitation by linking the photon receptor, rhodopsin, with a cyclic GMP phosphodiesterase (Pober & Bitensky, 1979; Stryer et al., 1981) .
Transducin is a heterotrimer with subunits of 39 kDa (Ta), 36 kDa (T) and approx. 8 kDa (T7) (Kuhn, 1980; Fung et al., 19M1) . Ta contains the guamne nucleotidebinding site and is a GTPase, although manifestation of this activity requires the presence of T and photolysed rhodopsin Fung, 19"3) . Transducin is homologous to the stimulatory (Ga) and inhibitory (G,) guanine nucleotide-binding regulatory proteins of adenylate cyclase (Manning & Gilman, 1983) ; these proteins also consist of a (45 and 41 kDa respectively), f6 (35 kDa) and y (5 kDa) subunits (Northup et al., 1980; Hildebrandt et al., 1984; Bokoch et al., 1983; Gilman, 1984) . G. and Gi, like transducin, are GTPases (Cassel & Selinger, 1976; Koski & Klee, 1981; Gilman, 1984) .
Choleragen activates adenylate cyclase by ADPribosylating the a-subunit of G8 (Cassel & Pfeuffer, 1978; Gill & Meren, 1978; Johnson et al., 1978; Gilman, 1984) ; this covalent modification inhibits the GTPase activity of G. and thus preserves the activated G8-GTP complex (Cassel & Selinger, 1977) . Similarly, choleragen ADPribosylates Ta in ROS, resulting in the inhibition of lightstimulated GTPase activity (Abood et al., 1982) . Pertussis toxin (also known as islet-activating protein) affects adenylate cyclase by ADP-ribosylating G,. (Katada & Ui, 1982a,b; Bokoch et al., 1983; Gilman, 1984) ; the rise in GTPase activity normally caused by agonists acting through inhibitory receptors is thereby prevented (Bums et al., 1983) . Ta is also ADP-ribosylated by pertussis toxin, leading to a decrease in light-stimulated GTPase activity (Van Dop et al., 1984a; . Thus, although the amino acid ADP-ribosylated in Ta by the two toxins differs (Van Dop et al., 1984b; West et al., 1985) , modification by either toxin decreases the lightstimulated ROS GTPase activity (Abood et al., 1982; Van Dop et al., 1984a; I To whom correspondence should be addressed.
Vol. 248 i749 purified from turkey erythrocytes (Moss & Vaughan, 1978; Moss et al., 1979 Moss et al., , 1980 . This enzyme ADPribosylates numerous proteins in both crude mixtures and purified protein preparations (Moss & Vaughan, 1_978; Watkins & Moss, 1982; Moss et al., 1984) ; however, the role of this transferase in the regulation of cellular metabolism remains unclear. As reported in the present paper, the erythrocyte transferase ADP-ribosylates transducin and this covalent modification results in decreased GTPase activity. A preliminary report of some of the present work has been published .
EXPERIMENTAL

Materials
-NAD+:arginine ADP-ribosyltransferase was purified to homogeneity from turkey erythrocyte cytosol as previously described (Moss et al., 1980) (1976) , with bovine plasma yglobulin as standard.
Preparation of ROS, transducin, transducin subunits and rhodopsin ,ROS membranes were prepared from dark-adapted bovine retinas under dim red light by the method of Fung & Stryer (1980) . Dark-adaptedretinal ROS, which were stored at -20°C, were photolysed by exposure to room light for at least 10 min immediately preceding incubation; all subsequent procedures were performed under normal room light. Transducin was extracted from photolysed ROS with 100# M-GTP as described by Kuhn (1980) and purified to homogeneity. T. was separated from Tfl on Blue Sepharose CL-6B (Kanaho et al., 1984) . khodopsin, purified to homogeneity from dark-adapted retinas by solubilization in 100 mM-dodecyltrimethylammonium bromide and chromatography on hydroxyapatite, was reconstituted in phosphatidylcholine vesicles (Hong & Hubbell, 1973) .
ADP-ribosylation of transducin and GTPase assay
Photolysed ROS (85-100 ,ug/assay) were incubated at 30°C with the NAD+: arginine ADP-ribosyltransferase (0.4-44 munits/assay) in a reaction mixture containing 50 mM-potassium phosphate buffer, pH 7.5, 20 mMthymidine, 0.2 M-NaCl, 1 mM-NAD' and other additions as indicated. After incubation, samples were removed for assay of GTPase activity . In ["2P]ADP-ribosylation experiments, purified transducin subunits were used instead of ROS, and 1 mM-[a-32P]NAD', 2-3 ,Ci/assay, replaced unlabelled NAD+. Reactions were terminated with ice-cold 10 % (w/v) trichloroacetic acid; precipitated proteins were sedimented at 2200 g for 15 min, solubilized in 1 %0 (w/v) SDS in the presence of 50 mM-dithiothreitol, and subjected to electrophoresis on 15 % polyacrylamide gels containing 0.1 % SDS (Laemmli, 1970 (Fig. 3) . ADP-ribosylation of Ta increased its apparent size on SDS/polyacrylamide-gel electrophoresis from 36 kDa to 38 kDa; all radioactivity was associated with the 38 kDa band (Fig. 3) Ta or T,,y the individual subunit preparations were first incubated with or without transferase before assay of GTPase in a reconstituted system with liposomes containing photolysed rhodopsin (Table 2) . Reconstitution of ADP-ribosyl-T. with unmodified Tp,, yielded only 20 % of the GTPase activity measured with unmodified T--Ty, (Table 2) . Conversely, 81 % ofcontrol GTPase activity was measured in a reconstituted system with unmodified Ta and ADP-ribosyl-T,,y (Table 2) .
When both Ta and T,, were ADP-ribosylated, GTPase activity was only 11 % of control activity (Table 2) . 
DISCUSSION
The present report demonstrates that ADP-ribosylation of transducin by an NAD+: arginine ADPribosyltransferase purified from turkey erythrocytes results in a decrease in GTPase activity. It is well documented that arginine residues in proteins can be critical for enzymic activity (Lange et al., 1974; Forster & Harrison, 1974; Borders & Riordan, 1975; Powers & Riordan, 1975) ; in most instances, the importance of the arginine residue was established by the use of chemical reagents such as phenylglyoxal, which display a selective reactivity for the guanidino group (Takahashi, 1968; Arnone et al., 1971; Daemen & Riordan, 1974; Lange et al., 1974; Borders & Riordan, 1975; Powers & Riordan, 1975) . With glutamine synthetases from sheep brain and chicken heart, it was shown that modification catalysed by the erythrocyte transferase resulted in the loss of the Mg2+-dependent activity . Thus the enzymic modification may be useful for identifying critical arginine residues. In the case of transducin, modification of Ta was critical to inhibition of GTPase.
Although TA, and photolysed rhodopsin have been shown to be necessary for expression of Ta GTPase activity Fung, 1983) , ADP-ribosylation of T.,, had only a small effect on GTPase activity. Van Dop et al. (1984a) reported a slight decrease in the mobility on SDS/polyacrylamide-gel electrophoresis of Ta that had been ADP-ribosylated by pertussis toxin. After modification by the erythrocyte transferase, both Ta and Tf8 exhibited decreased mobility. Since prolonged incubation of Ta with the erythrocyte transferase failed to alter the extent of incorporation of ADP-ribose into the 42 kDa or 46 kDa peptides, it is unlikely that the 42 kDa species (containing approx. 1 mol of ADPribose/mol of protein) is an 'intermediate' in the formation of the 46 kDa species (containing approx. 2 mol of ADP-ribose/mol of protein). The separation of two distinct ADP-ribosylated species of transferasetreated Ta is consistent with the hypothesis that Ta may consist of two non-identical peptides of very similar molecular mass that co-purified from ROS. More likely, however, minor changes in primary, secondary or tertiary structure of T. during purification or storage could have altered the availability of sites for ADP-ribosylation by the transferase.
The bacterial toxins choleragen and pertussis toxin inhibit the GTPase activity of transducin by ADPribosylating T., but neither toxin modifies Tfr,, in ROS.
Whereas choleragen ADP-ribosylated an arginine residue in T. (Van Dop et al., 1984b) , the acceptor site for pertussis toxin-catalysed ADP-ribosylation was a cysteine residue (West et al., 1985) .
Inhibition of ROS GTPase activity by choleragen but not pertussis toxin required the presence of p[NH]ppG (Abood et al., 1982; Van Dop et al., 1984a; (Navon & Fung, 1984) . In contrast, pertussis toxin is believed to inhibit GTPase by blocking the agonist-dependent binding to guanine nucleotides (Asano et al., 1984; Bruni et al., 1985) . In this respect, it appears that the mechanism of transferase-catalysed GTPase inhibition is more like that of pertussis toxin than that of choleragen. The difference in mechanism of action of choleragen and the erythrocyte transferase is interesting since both are NAD+: arginine ADP-ribosyltransferases. Both choleragen and the transferase ADP-ribosylate transducin; however, purified transducin is a poor substitute for choleragen (Abood et al., 1982) , whereas it is readily ADP-ribosylated by the transferase. Thus, with purified transducin, arginine residues available to the erythrocyte transferase are not readily accessible to the toxin. Under these conditions, the toxin is active, since the free amino acid as well as T. in ROS is readily ADP-ribosylated.
These studies are consistent with the hypothesis that different arginine residues are modified by choleragen and the erythrocyte transferase with different effects on the action of transducin.
